Excelsior Medical Co., Ltd. (TPE:4104)
85.00
+0.20 (0.24%)
Oct 23, 2025, 2:36 PM CST
Excelsior Medical Revenue
Excelsior Medical had revenue of 2.17B TWD in the quarter ending June 30, 2025, with 0.38% growth. This brings the company's revenue in the last twelve months to 8.65B, up 2.95% year-over-year. In the year 2024, Excelsior Medical had annual revenue of 8.54B with 3.71% growth.
Revenue (ttm)
8.65B
Revenue Growth
+2.95%
P/S Ratio
1.69
Revenue / Employee
62.71M
Employees
138
Market Cap
14.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.54B | 305.14M | 3.71% |
| Dec 31, 2023 | 8.23B | 1.05B | 14.56% |
| Dec 31, 2022 | 7.19B | 613.68M | 9.34% |
| Dec 31, 2021 | 6.57B | -102.34M | -1.53% |
| Dec 31, 2020 | 6.68B | 218.13M | 3.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.67B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |